FluoRok, a UK-based fluorochemical manufacturing technology company spun out of the University of Oxford, has raised $30 million in an oversubscribed Series A funding round to scale its manufacturing platform and expand fluorochemical production.

Orano Venture Fund and Supernova Invest led the funding round, with participation from Bidra Innovation Ventures. Existing investors Oxford Science Enterprises, BGF, GGF, Volta Energy Technologies, and the University of Oxford also participated.

FluoRok is developing a fluorochemical manufacturing process that eliminates the need for hydrogen fluoride (HF), commonly used in conventional production. The company says its process relies on mechanical activation rather than acid and high-temperature processing.

According to the release, the company has completed pilot qualifications and secured customers for its technology. The company plans to use the funding to build demonstrator facilities for fluorochemical reagents and lithium-ion battery electrolyte salts, expand its workforce, support larger-scale customer product validation, and build broader commercial partnerships.

According to the release, the Series A exceeded the company’s original fundraising target. FluoRok had previously raised $14 million  and secured more than $13 million in UK and European public funding.

The latest round also included angel investors and investment firms EverQuest Capital Partners, CPI Enterprises, and WS Investment. CPI Enterprises is also working with FluoRok as a scale-up partner.

The financing included approximately $1.3 million in grant funding from Innovate UK through its Investor Partnerships program.

Florian de Beauchaine, Investment Manager, Orano Venture Fund/Supernova Invest, stated, “We back companies whose technologies support a sovereign, sustainable industrial transition. FluoRok has already shown its process works at pilot scale, and taking hydrogen fluoride out of fluorochemical production tackles a safety and supply problem the whole industry shares. We are pleased to join a strong group of investors supporting the team as it moves to industrial scale.”

Fluorochemicals are used in pharmaceuticals, agrochemicals, and lithium-ion batteries. The company is initially targeting inorganic fluorides used in pharmaceutical and agrochemical applications and lithium hexafluorophosphate, commonly known as LiPF6, an electrolyte salt used in lithium-ion batteries.

According to Mercom’s recently released 9M 2026 Funding and M&A for Energy Storage report, VC funding for energy storage companies in 9M 2026 totaled $5.4 billion across 79 deals, representing a 93% YoY increase compared to $2.8 billion raised across 56 deals in 9M 2025.

In July, Battery materials company Sila raised $300 million in a private equity funding round to expand U.S. production of its silicon-carbon anode material and support the planned second phase of its manufacturing facility in Moses Lake, Washington.